Global Ventilator Demand Analysis-COVID-19 Impact (Feb-Dec 2020): Emphasis on Major COVID-19 Impacted Country
May 2020
135
About the Report
About the Report
Over the last few weeks, the coronavirus disease 2019 (COVID-19) pandemic has marched relentlessly westward. WHO stated that Europe was now the centre of the pandemic? A few days later, deaths in Spain surpassed those in Italy and China. Iran and United Kingdom had also reported over 30,000 deaths as of last week of April, and many other European countries and the USA reported increasing numbers of cases, heralding an imminent wave of fatalities. Following the sweep of COVID-19 is a series of dramatic containment measures that reflect the scale of the threat posed by the pandemic. Lockdowns that seemed draconian when instigated in Wuhan only 2 months ago are now becoming commonplace. However, many countries are still not following WHO's clear recommendations on containment (widespread testing, quarantine of cases, contact tracing, and social distancing) and have instead implemented haphazard measures, with some attempting only to suppress deaths by shielding the elderly and those with certain health conditions. The initial slow response in countries such as the UK, the USA, and Sweden now looks increasingly poorly judged. As leaders scramble to acquire diagnostic tests, personal protective equipment, and ventilators for overwhelmed hospitals, there is a growing sense of anger. The patchwork of harmful initial reactions from many leaders, from denial and misplaced optimism, to passive acceptance of large-scale deaths, was justified by words such as unprecedented. But this belies the damage wrought by SARS, Middle East respiratory syndrome, Ebola virus, Zika virus, the 2009 H1N1 influenza pandemic, and a widespread acceptance among scientists that a pandemic would one day occur. Hong Kong and South Korea were tested by these previous emerging infections, leaving them better able to scale up testing and contact tracing. Globally, many people are afraid, angry, uncertain, and without confidence in their national leadership. But alongside these dark sentiments, images of solidarity have emerged. Health workers have shown an incredible commitment to their communities and responded with compassion and resolve to tackle the virus despite challenging and sometimes dangerous conditions.
Key Highlights
The number of cases in the US has above 1,000,000 while New York is fast approaching towards crossing 310,839 cases alone, as of 30 April 2020
United Kingdom has overtaken France to become the fourth most impacted country, only behind the US, Italy and Spain, going by number of Covid-19 positive cases
The number of days taken to add 200,000 fresh cases to the global infected cases tally as well as the time taken to add 10,000 Covid-19 casualties is rapidly shortening. It took 122 days to reach the 200,000 mark since the first Covid-19 positive case was registered on 17th November in China and 67 days to cross 10,000 fatalities.
As of 30 April 2020, globally United States' share in the total death toll of Covid-19 was the highest in the world. In Europe, Italy's share then was 13.2% on 23 April but has since shrunk to 12% while France and Spain accounted for over 10% of the global fatalities.
Major reduction in the number of deaths has witnessed in Italy and Spain which were earlier accounting for almost half of the overall Covid-19 deaths in March. Apart from these four nations, the rest of the world accounted for almost 40% share in the overall daily death due to coronavirus.
At the time when the number of COVID-19 positive cases is rising by thousands each passing day, it is imperative to talk about the medical facilities that the countries currently possess. Ventilators are a much needed part of the facilities as they help a patient breathe when they have trouble breathing on their own. Countries across the world are short on ventilators but the country is all set to tackle this shortage. The data from China suggest that 15-20% of COVID-19 cases require hospitalization, with around 15% of cases presenting with severe symptoms and 5% requiring intensive care. In Italy and Spain, 40-55% of COVID-19 positive cases have been hospitalized, with 7-12% requiring admission to intensive care units. Estimates from China also suggest that patients in intensive care units (ICUs) require approximately 13 days of respiratory support, while data from Italy show that 10-25% of patients will require ventilation and some patients will need ventilation for several weeks. The deteriorating situation has raised serious questions about the level of critical care infrastructure across different countries, particularly that figure regarding ICU bed capacity. A study from the Chinese Center for Disease Control and Prevention found that while the vast majority of COVID-19 cases were mild up to that point, 13.8% were severe and 4.7% were critical. If the number of cases continues to climb at its current pace, intensive care units across the world will come under massive pressure. In order to show where that pressure could be highest, the following figure pulls together data from different sources to show the number of critical care beds per 100,000 inhabitants in different countries.
As the COVID-19 pandemic expands worldwide, with the United States now having the highest number of cases and exponentially increasing numbers of cases and deaths daily, the shortage of supplies is becoming paramount. The rapidly growing shortage of ventilators is also becoming of dire concern. Last year, 77,000 new ventilators were enough to meet the market demand of the entire planet. In April, New York City alone forecasts a need for 30,000 additional machines. Some ventilator manufacturers have already boosted their production by 30-50% but, by themselves, can't deliver the 500 or 1000% growth in production required. The top ventilator manufacturers-Gelinge, Hamilton Medical, Drager, Mindray, Medtronic, Lowenstein, Vyaire Medical, Philips, GE Heathcare, and Fisher & Paykel Healthcare, among others are today scaling up their production to meet the soaring demand. In addition, automakers have also announced they've been teaming up with existing ventilator makers to help them ramp up production. And some, like Ford, French automobile group PSA, Toyota, Maruti Suzuki, Mahindra & Mahindra, and GM are exploring producing ventilators in their own factories.
Products
Companies
Getinge, Hamilton Medical, Drager, Mindray, Medtronic, Lowenstein Medical UK, Vyaire Medical, Philips, General Electric, Fisher & Paykel Healthcare
Table of Contents
Table of Contents
1. MARKET INTRODUCTION 13
1.1 Market Definition 13
1.2 Objective of the Study 13
1.3 Limitation 13
1.4 Stakeholders 14
1.5 Currency used in the Report 14
1.6 Scope of the Ventilator Market Study 14
2. RESEARCH METHODOLOGY OR ASSUMPTION 15
2.1 Research Methodology for the Global Ventilator Demand Analysis-COVID-19 Impact 15
2.1.1 Main objective of the Global Ventilator Demand Analysis-COVID-19 Impact 16
3. EXECUTIVE SUMMARY 17
4. MARKET DYNAMICS 21
4.1 Market Introduction 21
4.1.1 Market Trend & Drivers 21
4.1.1.1 Growing Cases of COVID-19 21
4.1.1.2 Rising Number of ICU Beds 22
4.1.1.3 Rising Government Support 24
4.1.1.3.1 Initial Projects Approved 24
4.1.2 Market Challenges 26
4.1.2.1 Aviation Ban 26
4.1.2.2 Complications Associated With the Use of Ventilators 28
4.1.3 Market Opportunities 29
4.1.3.1 3D-Printed Ventilators 29
5. DEMAND AND SUPPLY SIDE ANALYSIS 30
5.1 Demand Side Analysis 30
5.2 Supply Side Analysis 31
5.2.1 Six tasks the supplier should keep a check on 32
5.2.1.1 Map the ventilator supply chain 32
5.2.1.2 Trace better pathways 32
5.2.1.3 Forecast demand 32
5.2.1.4 Recruit more help 32
5.2.1.5 Prepare the operators 32
5.2.1.6 Look for alternatives 32
5.2.2 Private Company and its initiatives for Ventilator production 33
5.2.2.1 Automotive OEM Initiatives 33
5.2.2.2 Electronic OEM Initiatives 34
5.2.2.3 Medical Device Manufacturer Initiatives 35
5.2.2.4 Other OEM Initiatives 36
6. MEDICAL DEVICE VALUE CHAIN 38
6.1 General Overview 38
7. VENTILATOR DEMAND INSIGHTS BY COUNTRY 40
7.1 General Overview 40
7.1.1 US Ventilator Demand-COVID-19 Impact 41
7.1.1.1 US Government's effort to secure more ventilators 42
7.1.1.2 Facts on COVID-19 Cases Feb-Dec 2020 44
7.1.1.3 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 44
7.1.1.4 UnivDatos Analysis on Ventilator Demand in the US amid COVID-19 45
7.1.2 Germany Ventilator Demand-COVID-19 Impact 45
7.1.2.1 Facts on COVID-19 Cases Feb-Dec 2020 46
7.1.2.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 47
7.1.2.3 UnivDatos Analysis on Ventilator Demand in Germany amid COVID-19 47
7.1.3 UK Ventilator Demand-COVID-19 Impact 47
7.1.3.1 Facts on COVID-19 Cases Feb-Dec 2020 48
7.1.3.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 49
7.1.3.3 UnivDatos Analysis on Ventilator Demand in the UK amid COVID-19 50
7.1.4 Italy Ventilator Demand-COVID-19 Impact 50
7.1.4.1 Facts on COVID-19 Cases Feb-Dec 2020 51
7.1.4.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 51
7.1.4.3 UnivDatos Analysis on Ventilator Demand in Italy amid COVID-19 52
7.1.5 France Ventilator Demand-COVID-19 Impact 52
7.1.5.1 Agile innovation by Private Players 53
7.1.5.2 Facts on COVID-19 Cases Feb-Dec 2020 53
7.1.5.3 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 54
7.1.5.4 UnivDatos Analysis on Ventilator Demand in France amid COVID-19 55
7.1.6 Spain Ventilator Demand-COVID-19 Impact 55
7.1.6.1 Facts on COVID-19 Cases Feb-Dec 2020 56
7.1.6.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 56
7.1.6.3 UnivDatos Analysis on Ventilator Demand in Spain amid COVID-19 57
7.1.7 Turkey Ventilator Demand-COVID-19 Impact 57
7.1.7.1 Facts on COVID-19 Cases Feb-Dec 2020 58
7.1.7.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 59
7.1.7.3 UnivDatos Analysis on Ventilator Demand in Turkey amid COVID-19 60
7.1.8 Iran Ventilator Demand-COVID-19 Impact 60
7.1.8.1 Facts on COVID-19 Cases Feb-Dec 2020 61
7.1.8.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 61
7.1.8.3 UnivDatos Analysis on Ventilator Demand in Iran amid COVID-19 62
7.1.9 Russia Ventilator Demand-COVID-19 Impact 62
7.1.9.1 Facts on COVID-19 Cases Feb-Dec 2020 63
7.1.9.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 64
7.1.9.3 UnivDatos Analysis on Ventilator Demand in Russia amid COVID-19 65
7.1.10 India Ventilator Demand-COVID-19 Impact 65
7.1.10.1 Facts on COVID-19 Cases Feb-Dec 2020 66
7.1.10.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 66
7.1.10.3 UnivDatos Analysis on Ventilator Demand in India amid COVID-19 67
7.1.11 Brazil Ventilator Demand-COVID-19 Impact 67
7.1.11.1 Facts on COVID-19 Cases Feb-Dec 2020 68
7.1.11.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 69
7.1.11.3 UnivDatos Analysis on Ventilator Demand in Brazil amid COVID-19 69
7.1.12 Rest of World Ventilator Demand-COVID-19 Impact 70
7.1.12.1 Facts on COVID-19 Cases Feb-Dec 2020 70
7.1.12.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 71
7.1.12.3 UnivDatos Analysis on Ventilator Demand in ROW amid COVID-19 72
8. COMPETITIVE SCENARIO 73
8.1 Competitive Landscape 73
8.1.1 Market Share of Key Players in Global Ventilator Market, 2019 73
9. TOP COMPANY PROFILES 74
9.1 Getinge AB 74
9.1.1 Key Facts 74
9.1.2 Business Description 75
9.1.3 Key Product/Services Offerings 76
9.1.4 Growth Strategy 77
9.1.5 SWOT Analysis 78
9.1.6 Key Financials 79
9.1.6.1 Revenue Split 80
9.1.7 Recent developments 80
9.1.7.1 Product Launch 80
9.1.7.2 Partnership 81
9.1.7.3 Business Expansion and Investment 81
9.1.7.4 Merger and Acquisitions 81
9.2 Hamilton Medical 82
9.2.1 Key Facts 82
9.2.2 Business Description 82
9.2.3 Key Product/Services Offerings 82
9.2.4 Growth Strategy 83
9.2.5 SWOT Analysis 83
9.2.6 Recent developments 84
9.2.6.1 Product Launch 84
9.2.6.2 Partnership 84
9.3 Dragerwerk AG 85
9.3.1 Key Facts 85
9.3.2 Business Description 85
9.3.3 Key Product/Services Offerings 86
9.3.4 Growth Strategy 87
9.3.5 SWOT Analysis 87
9.3.6 Key Financials 88
9.3.6.1 Revenue Split 89
9.3.7 Recent developments 89
9.3.7.1 Product Launch 89
9.3.7.2 Partnership 90
9.3.7.3 Business Expansion and Investment 90
9.3.7.4 Merger and Acquisitions 90
9.4 Mindray Medical International Limited 91
9.4.1 Key Facts 91
9.4.2 Business Description 91
9.4.3 Key Product/Services Offerings 92
9.4.4 Growth Strategy 92
9.4.5 SWOT Analysis 93
9.4.6 Recent developments 93
9.4.6.1 Partnership 93
9.5 Medtronic PLC 94
9.5.1 Key Facts 94
9.5.2 Business Description 95
9.5.3 Key Product/Services Offerings 95
9.5.4 Growth Strategy 96
9.5.5 SWOT Analysis 97
9.5.6 Key Financials 98
9.5.6.1 Revenue Split 99
9.5.7 Recent developments 99
9.5.7.1 Product Launch 99
9.5.7.2 Partnership 100
9.5.7.3 Business Expansion and Investment 100
9.5.7.4 Merger and Acquisitions 101
9.6 GE Healthcare 102
9.6.1 Key Facts 102
9.6.2 Business Description 102
9.6.3 Key Product/Services Offerings 103
9.6.4 Growth Strategy 103
9.6.5 SWOT Analysis 104
9.6.6 Key Financials 105
9.6.6.1 Revenue Split 106
9.6.7 Recent developments 106
9.6.7.1 Product Launch 106
9.6.7.2 Partnership 107
9.6.7.3 Business Expansion and Investment 107
9.7 Philips 108
9.7.1 Key Facts 108
9.7.2 Business Description 108
9.7.3 Key Product/Services Offerings 109
9.7.4 Growth Strategy 109
9.7.5 SWOT Analysis 110
9.7.6 Key Financials 111
9.7.6.1 Revenue Split 112
9.7.7 Recent developments 112
9.7.7.1 Product Launch 112
9.7.7.2 Partnership 113
9.7.7.3 Merger and Acquisitions 113
9.8 Fisher & Paykel Healthcare 114
9.8.1 Key Facts 114
9.8.2 Business Description 114
9.8.3 Key Product/Services Offerings 114
9.8.4 Growth Strategy 115
9.8.5 SWOT Analysis 116
9.8.6 Key Financials 117
9.8.6.1 Revenue Split 118
9.8.7 Recent developments 118
9.8.7.1 Product Launch 118
9.8.7.2 Partnership 119
9.9 VYAIRE Medical Inc. 120
9.9.1 Key Facts 120
9.9.2 Business Description 120
9.9.3 Key Product/Services Offerings 120
9.9.4 Growth Strategy 122
9.9.5 SWOT Analysis 122
9.9.6 Recent developments 123
9.9.6.1 Product Launch 123
9.9.6.2 Partnership 123
9.9.6.3 Business Expansion and Investment 123
9.10 ResMed 124
9.10.1 Key Facts 124
9.10.2 Business Description 124
9.10.3 Growth Strategy 126
9.10.4 SWOT Analysis 126
9.10.5 Key Financials 127
9.10.5.1 Revenue Split 128
9.10.6 Recent developments 128
9.10.6.1 Product Launch 128
9.10.6.2 Partnership 129
9.10.6.3 Merger and Acquisitions 129
List of Figure
FIG. 1 Scope of the Global Ventilator Demand Analysis-COVID-19 Impact 14
FIG. 2 Research Methodology for the Global Ventilator Demand Analysis-COVID-19 Impact 15
FIG. 3 Rapid Increase in Covid-19 Cases and Fatalities 18
FIG. 4 Country-wise Share in Daily Deaths due to Covid-19 18
FIG. 5 Countries with the Most Critical Care Beds Per 100,000 Inhabitants 19
FIG. 6 Global Ventilator Demand-COVID-19 Impact Feb-Dec 2020 (in units) 20
FIG. 7 Top Countries with Most COVID-19 Cases (in Units) 22
FIG. 8 Top Country with ICU Beds per 100,000 Population 23
FIG. 9 Intensive Care Beds in Community Hospitals in the US 23
FIG. 10 Initial Set of COVID-19 Emergency Response Projects Funded under the Fast-Track Facility, April 2020 26
FIG. 11 Flights Comparison (Passenger Capacity) 27
FIG. 12 Flights Comparison, Value in Millions (Passenger Capacity) 28
FIG. 13 Coronavirus Cases Severity 30
FIG. 14 Covid-19 Fatality Rate by Age Group 31
FIG. 15 Medical device categories and their relative technological complexity 38
FIG. 16 Value Chain Analysis 39
FIG. 17 Global Update on COVID-19 Cases, Globally 40
FIG. 18 Distribution of COVID-19 Cases, By Country 40
FIG. 19 Top Country with ICU Beds per 100,000 Population 41
FIG. 20 United States Ventilator Production Growth amid COVID-19 Outbreak 43
FIG. 21 US ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 45
FIG. 22 Germany ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 47
FIG. 23 UK ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 49
FIG. 24 Italy ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 52
FIG. 25 France ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 54
FIG. 26 Spain ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 57
FIG. 27 Turkey ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 59
FIG. 28 Iran ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 62
FIG. 29 Russia ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 64
FIG. 30 India ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 67
FIG. 31 Brazil ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 69
FIG. 32 ROW ICU Beds and Ventilator Demand-COVID-19 Impact (in Units) 71
FIG. 33 Market Share of Key Players in Global Ventilator Market, 2019 (%) 73
FIG. 34 Getinge AB Timeline 75
FIG. 35 Getinge AB Sustainable Development Goals 77
FIG. 36 Getinge AB SWOT Analysis 78
FIG. 37 Key Financials of Getinge AB 79
FIG. 38 Getinge AB Revenue Split, 2019 80
FIG. 39 Hamilton Medical SWOT Analysis 83
FIG. 40 Dragerwerk AG Timeline 86
FIG. 41 Dragerwerk AG SWOT Analysis 87
FIG. 42 Key Financials of Dragerwerk AG 88
FIG. 43 Dragerwerk AG Revenue Split, 2019 89
FIG. 44 Mindray Medical International Limited SWOT Analysis 93
FIG. 45 Medtronic PLC, Timeline 95
FIG. 46 Medtronic PLC, Key Facts 97
FIG. 47 Medtronic PLC, SWOT Analysis 97
FIG. 48 Key Financials of Medtronic PLC 98
FIG. 49 Medtronic PLC, Revenue Split, 2019 99
FIG. 50 GE Healthcare, Key Facts 104
FIG. 51 GE Healthcare, SWOT Analysis 104
FIG. 52 Key Financials of GE Healthcare (GE Electric Co.) 105
FIG. 53 GE Healthcare (GE Electric Co.), Revenue Split, 2019 106
FIG. 54 Philips, Business System 110
FIG. 55 Philips, SWOT Analysis 110
FIG. 56 Key Financials of Philips 111
FIG. 57 Philips, Revenue Split, 2019 112
FIG. 58 Fisher & Paykel Healthcare, Company's Value 115
FIG. 59 Fisher & Paykel Healthcare, SWOT Analysis 116
FIG. 60 Key Financials of Fisher & Paykel Healthcare 117
FIG. 61 Fisher & Paykel Healthcare, Revenue Split, 2019 118
FIG. 62 VYAIRE Medical Inc., SWOT Analysis 122
FIG. 63 ResMed, Achievements 125
FIG. 64 ResMed, SWOT Analysis 126
FIG. 65 Key Financials of ResMed 127
FIG. 66 ResMed, Revenue Split, 2019 128
List of Table
TABLE 1 List of Automotive OEM and their initiatives for Ventilator production 33
TABLE 2 List of Electronics OEM and their initiatives for Ventilator production 34
TABLE 3 List of Medical Devices Supplier and their initiatives for Ventilator production 35
TABLE 4 List of Consortium OEM and their initiatives for Ventilator production 36
TABLE 5 List of Other OEM and their initiatives for Ventilator production 36
TABLE 6 US Facts on COVID-19 Cases Feb-Jun 2020 (in units) 44
TABLE 7 US Ventilator Availability and Demand Amid Covid-19 44
TABLE 8 Germany Facts on COVID-19 Cases Feb-Jun 2020 (in units) 46
TABLE 9 Germany Ventilator Availability and Demand Amid Covid-19 47
TABLE 10 UK Facts on COVID-19 Cases Feb-Jun 2020 (in units) 48
TABLE 11 UK Ventilator Availability and Demand Amid Covid-19 49
TABLE 12 Italy Facts on COVID-19 Cases Feb-Jun 2020 (in units) 51
TABLE 13 Italy Ventilator Availability and Demand Amid Covid-19 51
TABLE 14 France Facts on COVID-19 Cases Feb-Jun 2020 (in units) 53
TABLE 15 France Ventilator Availability and Demand Amid Covid-19 54
TABLE 16 Spain Facts on COVID-19 Cases Feb-Jun 2020 (in units) 56
TABLE 17 Spain Ventilator Availability and Demand Amid Covid-19 56
TABLE 18 Turkey Facts on COVID-19 Cases Feb-Jun 2020 (in units) 58
TABLE 19 Turkey Ventilator Availability and Demand Amid Covid-19 59
TABLE 20 Iran Facts on COVID-19 Cases Feb-Jun 2020 (in units) 61
TABLE 21 Iran Ventilator Availability and Demand Amid Covid-19 61
TABLE 22 Russia Facts on COVID-19 Cases Feb-Jun 2020 (in units) 63
TABLE 23 Russia Ventilator Availability and Demand Amid Covid-19 64
TABLE 24 India Facts on COVID-19 Cases Feb-Jun 2020 (in units) 66
TABLE 25 India Ventilator Availability and Demand Amid Covid-19 66
TABLE 26 Brazil Facts on COVID-19 Cases Feb-Jun 2020 (in units) 68
TABLE 27 Brazil Ventilator Availability and Demand Amid Covid-19 69
TABLE 28 ROW Facts on COVID-19 Cases Feb-Jun 2020 (in units) 70
TABLE 29 ROW Ventilator Availability and Demand Amid Covid-19 71
TABLE 30 Getinge AB Key Facts 74
TABLE 31 Getinge AB Ownership Structure 74
TABLE 32 Products segmentation of Getinge AB 76
TABLE 33 Getinge AB Growth Strategy 77
TABLE 34 Getinge AB Product Launch 80
TABLE 35 Getinge AB Partnership 81
TABLE 36 Getinge AB Business Expansion and Investment 81
TABLE 37 Getinge AB Merger and Acquisitions 81
TABLE 38 Hamilton Medical Key Facts 82
TABLE 39 Products segmentation of Hamilton Medical 82
TABLE 40 Hamilton Medical Growth Strategy 83
TABLE 41 Hamilton Medical Product Launch 84
TABLE 42 Hamilton Medical Partnership 84
TABLE 43 Dragerwerk AG, Key Facts 85
TABLE 44 Dragerwerk AG Ownership Structure 85
TABLE 45 Products segmentation of Dragerwerk AG 86
TABLE 46 Dragerwerk AG Growth Strategy 87
TABLE 47 Dragerwerk AG Product Launch 89
TABLE 48 Dragerwerk AG Partnership 90
TABLE 49 Dragerwerk AG Business Expansion and Investment 90
TABLE 50 Dragerwerk AG Merger and Acquisitions 90
TABLE 51 Mindray Medical International Limited, Key Facts 91
TABLE 52 Products segmentation of Mindray Medical International Limited 92
TABLE 53 Mindray Medical International Limited Growth Strategy 92
TABLE 54 Mindray Medical International Limited Partnership 93
TABLE 55 Medtronic PLC, Key Facts 94
TABLE 56 Medtronic PLC, Ownership Structure 94
TABLE 57 Products segmentation of Medtronic PLC 95
TABLE 58 Medtronic PLC Growth Strategy 96
TABLE 59 Medtronic PLC, Product Launch 99
TABLE 60 Medtronic PLC, Partnership 100
TABLE 61 Medtronic PLC, Business Expansion and Investment 100
TABLE 62 Medtronic PLC, Merger and Acquisitions 101
TABLE 63 GE Healthcare, Key Facts 102
TABLE 64 Products segmentation of GE Healthcare 103
TABLE 65 GE Healthcare, Growth Strategy 103
TABLE 66 GE Healthcare, Product Launch 106
TABLE 67 GE Healthcare, Partnership 107
TABLE 68 GE Healthcare, Business Expansion and Investment 107
TABLE 69 Philips, Key Facts 108
TABLE 70 Philips, Ownership Structure 108
TABLE 71 Products segmentation of Philips 109
TABLE 72 Philips, Growth Strategy 109
TABLE 73 Philips, Product Launch 112
TABLE 74 Philips, Partnership 113
TABLE 75 Philips, Merger and Acquisitions 113
TABLE 76 Fisher & Paykel Healthcare, Key Facts 114
TABLE 77 Products segmentation of Fisher & Paykel Healthcare 114
TABLE 78 Fisher & Paykel Healthcare, Growth Strategy 115
TABLE 79 Fisher & Paykel Healthcare, Product Launch 118
TABLE 80 Fisher & Paykel Healthcare, Partnership 119
TABLE 81 VYAIRE Medical Inc., Key Facts 120
TABLE 82 Products segmentation of VYAIRE Medical Inc. 120
TABLE 83 VYAIRE Medical Inc., Growth Strategy 122
TABLE 84 VYAIRE Medical Inc., Product Launch 123
TABLE 85 VYAIRE Medical Inc., Partnership 123
TABLE 86 VYAIRE Medical Inc., Business Expansion and Investment 123
TABLE 87 ResMed, Key Facts 124
TABLE 88 ResMed Ownership Structure 124
TABLE 89 Products segmentation of ResMed 125
TABLE 90 ResMed, Growth Strategy 126
TABLE 91 ResMed, Product Launch 128
TABLE 92 ResMed, Partnership 129
TABLE 93 ResMed, Merger and Acquisitions 129
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.